BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1178961)

  • 1. [Thermoliability of alkaline phosphatase in patients on hemodialysis].
    Botey A; Matamoros N; Revert L
    Rev Clin Esp; 1975 Jul; 138(2):155-62. PubMed ID: 1178961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alkaline phosphatase in patients with chronic renal insufficiency. Histochemical picture in the bone isoenzyme activity (author's transl)].
    Horn V; Vokrouhlická O; Stĕpán J; Erben J; Pacovský V
    Cas Lek Cesk; 1977 Sep; 116(38):1165-70. PubMed ID: 922783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oxaloacetic transaminase, lactate dehydrogenase, alkaline phosphatase and bilirubin in patients on chronic hemodialysis].
    Degoulet P; Rahmi R; Piette Y
    Union Med Can; 1973 Aug; 103(8):1644-9. PubMed ID: 4792851
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of programmed hemodialysis on serum alkaline phosphatase in patients with chronic renal insufficiency].
    Basova NI; Zavarzina TM; Terekhov NT; Petrun' NM
    Vrach Delo; 1977 Jul; (7):99-103. PubMed ID: 898887
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum alkaline phosphatase as indicator of the liver and bone involvement in patients treated by chronic dialysis].
    Stĕpán J; Pilarová T; Votrubová O; Melicharová D
    Cas Lek Cesk; 1974 Aug; 113(31):952-7. PubMed ID: 4447961
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkaline phosphatase activity in leukocytes of patients with renal failure treated with dialyses.
    Kuska J
    Pol Med J; 1971; 10(3):570-6. PubMed ID: 5124125
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
    Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
    Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Alkaline phosphatases in patients in chronic hemodialysis].
    Wauters JP; Balant L; Leski M; Fabre J; Rosenbusch CA
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1774-6. PubMed ID: 1215974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W
    Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum alkaline phosphatases as an indicator of liver and bone disease in chronically dialyzed patients].
    Stĕpán J; Pilarová T; Votrubová O; Melicharová D
    Cas Lek Cesk; 1974 Aug; 113(31):952-7. PubMed ID: 4410849
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofibrate effect on alkaline phosphatase in renal failure.
    Kijima Y; Sasaoka T; Kanayama M; Kubota S
    N Engl J Med; 1977 Jul; 297(2):113. PubMed ID: 865570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency].
    Sánchez Navarro MR; Fernández-Conde ME; Blanco Martín S; Samaniego C
    An Med Interna; 2002 Sep; 19(9):449-52. PubMed ID: 12420628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V; Cutrupi S; Pizzini P; Mallamaci F; Tripepi G; Zoccali C
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of alkaline phosphatase of leukocytes in patients with renal failure treated with dialysis].
    Kuska J
    Pol Arch Med Wewn; 1970 Jun; 44(6):609-15. PubMed ID: 5449801
    [No Abstract]   [Full Text] [Related]  

  • 17. Paget's disease of bone in a patient on hemodialysis.
    Etemadi J; Bagheri N; Falaknazi K; Ardalan M; Rahbar K; Nobakht Haghighi A; Mohajel Shoja M
    Iran J Kidney Dis; 2008 Apr; 2(2):105-7. PubMed ID: 19377219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of parathyroid hormone on bone resorption in uremic patients.
    Arata RO; Campos C; Mautalen CA
    Medicina (B Aires); 1976; 36(2):113-20. PubMed ID: 933833
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proposal for a system of checking of hematochemical data and its importance in the evaluation of the efficacy of regular hemodialysis treatment].
    Stratta P; Dogliani M; Segoloni G; Rotunno M; Triolo G; Piccoli G; Martini PF
    Minerva Med; 1973 Dec; 64(89):4669-85. PubMed ID: 4775166
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of heparin on the activity of plasma enzymes in patients on intermittent haemodialysis (author'r transl)].
    Zazgornik J
    Wien Klin Wochenschr; 1974 Oct; 86(19):563-90. PubMed ID: 4154534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.